Scientific Expertise

Beta-Actin, a protein that helps determine cell shape and movement, is consistently detected in various sample types and is widely used in molecular assays. This bulletin evaluates its reliability and utility as an internal control for ensuring specimen quality and validating molecular assays in clinical settings.

In a significant development for the pharmaceutical and clinical trial industries, we proudly announce a strong collaborative effort of Eurofins companies dedicated to clinical trial testing in support of drug and vaccine development. Under the new brand of Eurofins Clinical Trial Solutions, we emphasize our expanded commitment to offering global comprehensive, collaborative solutions for the complex challenges of modern drug development.

Gene therapy offers groundbreaking solutions by delivering genetic material to correct or compensate for flawed proteins. While AAV vectors have shown significant potential due to their improved safety profile and tissue specificity, challenges remain—particularly when it comes to managing immune responses.

Chimeric antigen receptor (CAR) T cell therapy has transformed hematological cancer treatment, with six therapies now approved by the FDA. Four of these therapies (tisa-cel, axi-cel, brexu-cel, and liso-cel) target CD19 using single chain variable fragments (scFvs) derived from the heavy and light chain variable (VH and VL) regions of the monoclonal antibody FMC63.

October 30, 2024

In this webinar, they will discuss the development and validation of a sensitive, reproducible, and robust client-specific AAV qPCR assay intended for use in viral shedding studies.

Monitoring CAR T-cells post-infusion in clinical trials using flow cytometry requires a robust, standardized assay to generate valuable and reliable data for therapy monitoring and biomarker identification.

August 8, 2024

Our experts guide you through the general timelines and critical steps for taking a biotherapeutic project from initial lab engagement to final data reporting to help you avoid potential roadblocks.

In this white paper, we outline the validation experiments and performance attributes of quantitative BRAF^V600E mutation detection assays conducted using ddPCR at Eurofins Viracor BioPharma.

Strategies for the Modernization of Legacy Transfer Methods